title: Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology.
authors.affiliation: Research Infrastructure, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy. albini.adriana@gmail.com
authors.forename: Adriana
authors.initials: A
authors.lastname: Albini
authors.forename: Francesco
authors.initials: F
authors.lastname: Donatelli
authors.forename: Chiara
authors.initials: C
authors.lastname: Focaccetti
authors.forename: Mario Milco
authors.initials: MM
authors.lastname: D'Elios
authors.forename: Douglas M
authors.initials: DM
authors.lastname: Noonan
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D051437:Renal Insufficiency / Q000150:complications*; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068878:Trastuzumab